SPC Financial Inc. Buys 154 Shares of Encompass Health Co. (NYSE:EHC)

SPC Financial Inc. grew its holdings in Encompass Health Co. (NYSE:EHC) by 0.3% during the 4th quarter, Holdings Channel reports. The firm owned 45,077 shares of the company’s stock after purchasing an additional 154 shares during the period. SPC Financial Inc.’s holdings in Encompass Health were worth $4,163,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB raised its holdings in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after buying an additional 137 shares during the period. Avior Wealth Management LLC bought a new position in shares of Encompass Health in the third quarter valued at $40,000. Tompkins Financial Corp bought a new position in Encompass Health during the fourth quarter worth $46,000. V Square Quantitative Management LLC lifted its holdings in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after buying an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new stake in shares of Encompass Health during the third quarter worth $68,000. Institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on EHC. Barclays boosted their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Finally, StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Down 1.2 %

Shares of NYSE:EHC opened at $98.55 on Wednesday. The stock has a fifty day simple moving average of $96.62 and a two-hundred day simple moving average of $96.57. The stock has a market capitalization of $9.93 billion, a price-to-earnings ratio of 22.10, a PEG ratio of 2.31 and a beta of 0.90. Encompass Health Co. has a 12-month low of $74.27 and a 12-month high of $104.55. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.